Ionis Pharmaceuticals IncNASDAQ:IONS
- LAST PRICE39.2100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots38.5500/ 1
- Ask / Lots39.0000/ 2
- Open / Previous Close0.0000 / 39.2100
- Day Range---
- 52 Week Range
- Volume6,118
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | IONS |
|---|---|---|
| 09:32 ET | 9614 | 38.625 |
| 09:34 ET | 500 | 39.03 |
| 09:36 ET | 1955 | 39.07 |
| 09:38 ET | 1237 | 39.08 |
| 09:39 ET | 644 | 39.07 |
| 09:41 ET | 614 | 39.05 |
| 09:43 ET | 1127 | 38.915 |
| 09:45 ET | 500 | 38.85 |
| 09:48 ET | 2083 | 38.93 |
| 09:50 ET | 2550 | 39.01 |
| 09:52 ET | 200 | 38.98 |
| 09:54 ET | 2633 | 39.03 |
| 09:56 ET | 1000 | 39.11 |
| 09:57 ET | 4900 | 39.3 |
| 09:59 ET | 2835 | 39.3 |
| 10:01 ET | 2253 | 39.265 |
| 10:03 ET | 2397 | 39.1 |
| 10:06 ET | 200 | 39.02 |
| 10:08 ET | 1935 | 39.14 |
| 10:10 ET | 602 | 39.14 |
| 10:12 ET | 400 | 39.09 |
| 10:14 ET | 1400 | 39.16 |
| 10:15 ET | 4655 | 39.1 |
| 10:17 ET | 2000 | 39.21 |
| 10:21 ET | 1500 | 39.32 |
| 10:24 ET | 200 | 39.36 |
| 10:26 ET | 900 | 39.32 |
| 10:28 ET | 200 | 39.3 |
| 10:30 ET | 300 | 39.32 |
| 10:32 ET | 268 | 39.32 |
| 10:33 ET | 932 | 39.35 |
| 10:35 ET | 11999 | 39.4 |
| 10:37 ET | 15987 | 39.37 |
| 10:39 ET | 5081 | 39.445 |
| 10:42 ET | 880 | 39.48 |
| 10:44 ET | 12033 | 39.48 |
| 10:46 ET | 1034 | 39.49 |
| 10:48 ET | 851 | 39.47 |
| 10:50 ET | 1050 | 39.5 |
| 10:51 ET | 918 | 39.52 |
| 10:53 ET | 2256 | 39.49 |
| 10:55 ET | 1500 | 39.475 |
| 10:57 ET | 2051 | 39.48 |
| 11:00 ET | 6697 | 39.44 |
| 11:02 ET | 15651 | 39.575 |
| 11:04 ET | 2118 | 39.62 |
| 11:06 ET | 909 | 39.68 |
| 11:08 ET | 1914 | 39.69 |
| 11:09 ET | 300 | 39.715 |
| 11:11 ET | 1326 | 39.72 |
| 11:13 ET | 2300 | 39.745 |
| 11:15 ET | 400 | 39.75 |
| 11:18 ET | 46513 | 39.68 |
| 11:20 ET | 7645 | 39.74 |
| 11:22 ET | 1500 | 39.69 |
| 11:24 ET | 400 | 39.63 |
| 11:26 ET | 800 | 39.66 |
| 11:27 ET | 857 | 39.66 |
| 11:29 ET | 1090 | 39.69 |
| 11:31 ET | 600 | 39.67 |
| 11:33 ET | 9557 | 39.655 |
| 11:36 ET | 665 | 39.71 |
| 11:38 ET | 14700 | 39.69 |
| 11:40 ET | 100 | 39.66 |
| 11:42 ET | 600 | 39.705 |
| 11:44 ET | 3686 | 39.6 |
| 11:45 ET | 400 | 39.615 |
| 11:47 ET | 341 | 39.615 |
| 11:49 ET | 600 | 39.6 |
| 11:51 ET | 2352 | 39.57 |
| 11:54 ET | 600 | 39.59 |
| 11:56 ET | 895 | 39.63 |
| 11:58 ET | 4746 | 39.64 |
| 12:00 ET | 6673 | 39.64 |
| 12:02 ET | 5875 | 39.65 |
| 12:03 ET | 1100 | 39.62 |
| 12:05 ET | 1100 | 39.635 |
| 12:07 ET | 600 | 39.625 |
| 12:09 ET | 200 | 39.625 |
| 12:12 ET | 458 | 39.6152 |
| 12:14 ET | 1953 | 39.57 |
| 12:16 ET | 1500 | 39.59 |
| 12:18 ET | 456 | 39.59 |
| 12:20 ET | 400 | 39.61 |
| 12:21 ET | 918 | 39.56 |
| 12:23 ET | 630 | 39.49 |
| 12:25 ET | 1817 | 39.36 |
| 12:27 ET | 1900 | 39.35 |
| 12:30 ET | 800 | 39.32 |
| 12:32 ET | 1720 | 39.31 |
| 12:34 ET | 600 | 39.3 |
| 12:38 ET | 817 | 39.28 |
| 12:39 ET | 1200 | 39.26 |
| 12:41 ET | 300 | 39.25 |
| 12:43 ET | 700 | 39.24 |
| 12:45 ET | 100 | 39.265 |
| 12:48 ET | 300 | 39.28 |
| 12:50 ET | 2150 | 39.31 |
| 12:52 ET | 1834 | 39.36 |
| 12:54 ET | 100 | 39.35 |
| 12:56 ET | 1200 | 39.37 |
| 12:57 ET | 232 | 39.395 |
| 12:59 ET | 300 | 39.39 |
| 01:01 ET | 2411 | 39.27 |
| 01:03 ET | 100 | 39.27 |
| 01:06 ET | 300 | 39.26 |
| 01:08 ET | 100 | 39.29 |
| 01:10 ET | 203 | 39.265 |
| 01:12 ET | 1507 | 39.29 |
| 01:15 ET | 100 | 39.29 |
| 01:17 ET | 2443 | 39.3 |
| 01:21 ET | 809 | 39.215 |
| 01:24 ET | 397 | 39.21 |
| 01:26 ET | 1415 | 39.24 |
| 01:28 ET | 200 | 39.22 |
| 01:30 ET | 200 | 39.2317 |
| 01:32 ET | 729 | 39.265 |
| 01:33 ET | 828 | 39.23 |
| 01:35 ET | 300 | 39.24 |
| 01:37 ET | 200 | 39.23 |
| 01:39 ET | 200 | 39.22 |
| 01:42 ET | 700 | 39.25 |
| 01:44 ET | 500 | 39.2309 |
| 01:46 ET | 100 | 39.23 |
| 01:48 ET | 1200 | 39.18 |
| 01:50 ET | 400 | 39.17 |
| 01:51 ET | 3200 | 39.28 |
| 01:53 ET | 300 | 39.29 |
| 01:55 ET | 396 | 39.27 |
| 01:57 ET | 100 | 39.25 |
| 02:00 ET | 500 | 39.22 |
| 02:02 ET | 200 | 39.23 |
| 02:04 ET | 2105 | 39.21 |
| 02:06 ET | 1506 | 39.18 |
| 02:08 ET | 400 | 39.19 |
| 02:09 ET | 400 | 39.195 |
| 02:11 ET | 100 | 39.19 |
| 02:13 ET | 1900 | 39.195 |
| 02:15 ET | 100 | 39.21 |
| 02:18 ET | 1610 | 39.17 |
| 02:20 ET | 100 | 39.14 |
| 02:22 ET | 1000 | 39.15 |
| 02:27 ET | 500 | 39.14 |
| 02:29 ET | 800 | 39.2 |
| 02:31 ET | 82200 | 39.12 |
| 02:33 ET | 5261 | 39.225 |
| 02:36 ET | 1015 | 39.225 |
| 02:38 ET | 163 | 39.27 |
| 02:40 ET | 1300 | 39.35 |
| 02:42 ET | 2088 | 39.33 |
| 02:44 ET | 3400 | 39.32 |
| 02:45 ET | 900 | 39.35 |
| 02:47 ET | 800 | 39.37 |
| 02:49 ET | 1400 | 39.34 |
| 02:51 ET | 1200 | 39.335 |
| 02:54 ET | 500 | 39.33 |
| 02:56 ET | 700 | 39.32 |
| 02:58 ET | 1533 | 39.3 |
| 03:00 ET | 2104 | 39.33 |
| 03:02 ET | 1560 | 39.375 |
| 03:03 ET | 3254 | 39.42 |
| 03:05 ET | 29300 | 39.43 |
| 03:07 ET | 1678 | 39.435 |
| 03:09 ET | 14302 | 39.38 |
| 03:12 ET | 1500 | 39.32 |
| 03:14 ET | 1500 | 39.34 |
| 03:16 ET | 2809 | 39.33 |
| 03:18 ET | 7786 | 39.335 |
| 03:20 ET | 1000 | 39.325 |
| 03:21 ET | 2500 | 39.27 |
| 03:23 ET | 1200 | 39.24 |
| 03:25 ET | 1683 | 39.2306 |
| 03:27 ET | 1327 | 39.2 |
| 03:30 ET | 5238 | 39.09 |
| 03:32 ET | 2300 | 39.06 |
| 03:34 ET | 2056 | 39.09 |
| 03:36 ET | 2182 | 39.14 |
| 03:38 ET | 2350 | 39.14 |
| 03:39 ET | 1350 | 39.16 |
| 03:41 ET | 2959 | 39.12 |
| 03:43 ET | 5102 | 39.15 |
| 03:45 ET | 4399 | 39.2 |
| 03:48 ET | 5317 | 39.2 |
| 03:50 ET | 3085 | 39.1 |
| 03:52 ET | 6177 | 39.14 |
| 03:54 ET | 9661 | 39.18 |
| 03:56 ET | 10934 | 39.21 |
| 03:57 ET | 9409 | 39.26 |
| 03:59 ET | 16093 | 39.21 |
Today
DJ Biogen, Ionis Terminate Development of BIIB105 for Amyotrophic Lateral Sclerosis, from 1 hour ago by Dow Jones
1 hour ago by Dow JonesIonis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis, from 1 hour ago by Dow Jones
1 hour ago by Dow JonesBiogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis, from 1 hour ago by Dow Jones
1 hour ago by Dow JonesIonis announces positive topline results from Phase 1/2a trial of ION582 for Angelman syndrome, from 2 hours ago by Dow Jones
2 hours ago by Dow Jones
Yesterday
Ionis to host 2024 virtual Annual Meeting of Stockholders, from 7:05AM ET on Wednesday May 15, 2024 by Dow Jones
7:05AM ET on Wednesday May 15, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Ionis Pharmaceuticals Inc | 5.7B | -14.7x | --- |
Halozyme Therapeutics Inc | 5.8B | 19.0x | --- |
Apellis Pharmaceuticals Inc | 5.1B | -12.1x | --- |
Intra-Cellular Therapies Inc | 7.1B | -58.0x | --- |
CRISPR Therapeutics AG | 4.8B | -21.1x | --- |
ACADIA Pharmaceuticals Inc | 2.5B | -1,174.8x | --- |
Company Information
Ionis Pharmaceuticals, Inc. is engaged in ribonucleic acid (RNA)-targeted therapeutics. The Company has five marketed medicines and a pipeline in neurology, cardiology, and other areas of high patient need. It has nine medicines in Phase III development and multiple additional medicines in early and mid-stage development. The Company’s products include SPINRAZA, QALSODY, WAINUA, TEGSEDI and WAYLIVRA. SPINRAZA is used for the treatment of patients with spinal muscular atrophy (SMA), a progressive, debilitating and often fatal genetic disease. QALSODY is an antisense medicine that is used for the treatment of adult patients with superoxide dismutase 1 amyotrophic lateral sclerosis (SOD1-ALS), a rare, neurodegenerative disorder that causes progressive loss of motor neurons leading to death. WAINUA is a self-administered subcutaneous LIgand-Conjugated Antisense (LICA) medicine used for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated amyloidosis (ATTRv-PN).
Contact Information
- Headquarters
- 2855 Gazelle CourtCARLSBAD, CA, United States 92010
- Phone
- 760-931-9200
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Joseph Loscalzo
- Chief Executive Officer, Director
- Brett Monia
- Chief Financial Officer, Executive Vice President - Finance
- Elizabeth Hougen
- Executive Vice President, Chief Scientific Officer
- C. Frank Bennett
- Executive Vice President, Chief Business Officer
- Joseph Baroldi
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.7B |
|---|---|
Revenue (TTM) | $776.6M |
Shares Outstanding | 146.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.35 |
EPS | $-2.67 |
Book Value | $2.68 |
P/E Ratio | -14.7x |
Price/Sales (TTM) | 7.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -45.47% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
